Variant allele frequency: a decision-making tool in precision oncology?-Reference-Cited by-同舟云学术

Variant allele frequency: a decision-making tool in precision oncology?

Published:2023-12 Issue:12 Volume:9 Page:1058-1068
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Boscolo Bielo Luca,Trapani Dario,Repetto Matteo,Crimini Edoardo,Valenza Carmine,Belli Carmen,Criscitiello Carmen,Marra Antonio,Subbiah Vivek,Curigliano Giuseppe^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference77 articles.

1. Precision oncology: origins, optimism, and potential;Prasad;Lancet Oncol.,2016

2. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing;Gerlinger;N. Engl. J. Med.,2012

3. The influence of subclonal resistance mutations on targeted cancer therapy;Schmitt;Nat. Rev. Clin. Oncol.,2016

4. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT);Cheng;J. Mol. Diagn.,2015

5. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing;Shen;Nucleic Acids Res.,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-Exome Sequencing Reveals Novel Candidate Driver Mutations and Potential Druggable Mutations in Patients with High-Risk Neuroblastoma;Journal of Personalized Medicine;2024-09-08

2. Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia;Biological Research;2024-09-03

3. Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma;Cancer Treatment Reviews;2024-09

4. Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild type metastatic colorectal cancer in the CAPRI 2-GOIM trial;Annals of Oncology;2024-08

5. The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer;International Journal of Molecular Sciences;2024-07-19